Prosight Management’s Medtronic MDT Stock Holding History

Prosight Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$2.36M	–	55
2024 Q2	$2.36M	Sell	30,000 -150,000	-83%	-$12.3M	0.71%	30
2024 Q1	$15.7M	Sell	180,000 -40,000	-18%	-$3.41M	4.36%	9
2023 Q4	$18.1M	Buy	220,000 +70,000	+47%	+$5.33M	7.28%	4
2023 Q3	$11.8M	Buy	150,000 +90,000	+150%	+$7.53M	3.73%	8
2023 Q2	$5.29M	Buy	+60,000	New	+$5.17M	1.55%	22
2021 Q3	–	Sell	-11,000	Closed	-$1.36M	–	49
2021 Q2	$1.36M	Sell	11,000 -9,088	-45%	-$1.14M	0.85%	27
2021 Q1	$2.37M	Buy	+20,088	New	+$2.35M	1.94%	19

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prosight Management's MDT Position: Q3 2024 in Review

Prosight Management sold out of Medtronic (MDT) in Q3 2024, closing a stake of 30,000 shares — an estimated $2.36M sold.

Prosight Management first reported a position in MDT in Q1 2021 and held it in 7 quarters. The position peaked at $18.1M in Q4 2023. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

Prosight Management reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
Prosight Management sold 30,000 Medtronic shares in Q3 2024, an estimated $2.36M.
Prosight Management first reported a position in Medtronic in Q1 2021 and held it in 7 quarters.
Prosight Management's Medtronic position peaked at $18.1M in Q4 2023.
2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Prosight Management's 13F filing for Q3 2024, filed 14 Nov 2024.